Outlook Therapeutics
OTLK
#9571
Rank
ยฃ27.74 M
Marketcap
ยฃ1.17
Share price
3.52%
Change (1 day)
-83.33%
Change (1 year)

Revenue for Outlook Therapeutics (OTLK)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Outlook Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A-100%
2019 ยฃ5.39 M102.53%
2018 ยฃ2.66 M-15.84%
2017 ยฃ3.16 M70.81%
2016 ยฃ1.85 M-16.22%
2015 ยฃ2.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.46 BN/A Jersey
ยฃ0.67 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.08 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ17.42 MN/A๐Ÿ‡ฌ๐Ÿ‡ง UK